"BPC 157 and standard angiogenic growth factors: effect on angiogenesis in healing." Eur J Pharmacol
Post-Treatment Care Avoid direct sun exposure and use a broad-spectrum sunscreen daily to protect your results
International Program on Chemical Safety: Global assessment of the state-of-the-science of endocrine disruptors: an assessment prepared by an expert group on behalf of the World Health Organization, the International Labour Organisation, and the United Nations Environment Programme
Meyer A, Laverny G, Allenbach Y, Grelet E, Ueberschlag V, Echaniz-Laguna A, et al
Carnforth, UK: Marius Press, 1997 Malik RA, Williamson S, Abbott CA, et al
The FDA says that they would not take action against a compounder for using a Category 1 substance but would consider taking action for those that use Category 2 or 3 substances